Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Bournaud

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
European Journal of Endocrinology|September 30, 2003
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?Francesco Giammarile, Zakia Hafdi, Claire Bournaud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
131I effective half-life and dosimetry in thyroid cancer patientsHervé Remy, Isabelle Borget, Sophie Leboulleux, et al.
Thyroid : Official Journal of the American Thyroid Association|April 4, 2012
Pregnant French women living in the Lyon area are iodine deficient and have elevated serum thyroglobulin concentrationsVéronique Raverot, Claire Bournaud, Geneviève Sassolas, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Lucien Marchand, Cécile Nozières, Thomas Walter, et al.
European Journal of Endocrinology|October 3, 2009
Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhône-Alpes Région of FranceGeneviève Sassolas, Zakia Hafdi-Nejjari, Anne Marie Schott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2021
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancerDésirée Deandreis, Aline Maillard, Slimane Zerdoud, et al.
Scientific Reports|February 27, 2026
[¹¹C]Methionine PET uptake kinetics in corticotroph pituitary neuroendocrine tumorsAnthime Flaus, Armand Pattée, Guillaume Criton, et al.
Nuclear Medicine Communications|July 14, 2017
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomasAurélie Moreau, Anne L Giraudet, David Kryza, et al.
Clinical Nuclear Medicine|March 21, 2017
FDOPA Patterns in Adrenal Glands: A Pictorial EssayAurélie Moreau, Anne Laure Giraudet, David Kryza, et al.
Cancers|June 10, 2022
Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC)Nadia Bouzehouane, Pascal Roy, Myriam Decaussin-Petrucci, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
European Journal of Endocrinology|September 30, 2003
Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?Francesco Giammarile, Zakia Hafdi, Claire Bournaud, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 16, 2008
131I effective half-life and dosimetry in thyroid cancer patientsHervé Remy, Isabelle Borget, Sophie Leboulleux, et al.
Thyroid : Official Journal of the American Thyroid Association|April 4, 2012
Pregnant French women living in the Lyon area are iodine deficient and have elevated serum thyroglobulin concentrationsVéronique Raverot, Claire Bournaud, Geneviève Sassolas, et al.
Acta Oncologica (Stockholm, Sweden)|May 14, 2016
Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?Lucien Marchand, Cécile Nozières, Thomas Walter, et al.
European Journal of Endocrinology|October 3, 2009
Geographical correlation between incidence of benign disease and that of cancer of the thyroid among the population of the Rhône-Alpes Région of FranceGeneviève Sassolas, Zakia Hafdi-Nejjari, Anne Marie Schott, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2021
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancerDésirée Deandreis, Aline Maillard, Slimane Zerdoud, et al.
Scientific Reports|February 27, 2026
[¹¹C]Methionine PET uptake kinetics in corticotroph pituitary neuroendocrine tumorsAnthime Flaus, Armand Pattée, Guillaume Criton, et al.
Nuclear Medicine Communications|July 14, 2017
Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomasAurélie Moreau, Anne L Giraudet, David Kryza, et al.
Clinical Nuclear Medicine|March 21, 2017
FDOPA Patterns in Adrenal Glands: A Pictorial EssayAurélie Moreau, Anne Laure Giraudet, David Kryza, et al.
Cancers|June 10, 2022
Prognostic Impact of Microscopic Extra-Thyroidal Extension (mETE) on Disease Free Survival in Patients with Papillary Thyroid Carcinoma (PTC)Nadia Bouzehouane, Pascal Roy, Myriam Decaussin-Petrucci, et al.
Pageof 6